TargetingWhat Matters
We discover novel, prevalent, and disease-specific drug targets through AI-driven analysis of RNA splicing. Our team combines deep expertise in RNA biology and AI to advance transformative treatments in immuno-oncology and RNA-targeted treatments for neurodegenerative diseases.
Envisagenics Path to Precision Medicines
2014
Company founded
2015 - 2017
Platform Development
- Regional investment (Long Island) and NIH Phl grant awarded
- Completed pilot project with first strategic partner
- Thiel Foundation’s Breakout Labs recipient
- Seed financing
- Won AI for Drug Discovery QuickFire Challenge (J&J)
- Won Innovate.AI challenge (M12 and Madrona Venture Group)
2018 - 2021
Target Identification & Validation
- Established wet lab at JLABS@NYC
- NIH grant awarded (PhI & PhII)
- Research development agreement with J&J
- Research collaboration agreement with Biogen
- Series A financing
2022 - Beyond
Therapeutic Development & Partnerships
- Research collaboration agreement with BMS
- NIH PhII grant awarded
- Series B financing with institutional investor
Leadership
A Leadership Team Driving Scientific and Strategic Impact
Maria Pineda, PhD
CEO & Co-founderBoard Member
Martin Akerman, PhD
CEO & Co-founderBoard Member
Bradley Harris, JD
COO & General Counsel
Sudhir Rao, MS MBA
CBO
Gayatri Arun, PhD
EVP of BiologyBoard of Directors & Scientific Advisory Board
A Trusted Network of Scientific and Strategic Advisors
Michael Grissinger, MBA
Johnson & Johnson Executive,Business DevelopmentBOD
Kalpana Merchant, PhD
Eli Lilly & Company R&D expert, former CSOBOD
Grant Verstandig
Rally Health, UHCFormer CDOBOD
Silvia Garcia Codony
Empire State DevelopmentAssoc. Vice President, NY VenturesBoard Observer
Peter Strack, PhD
BMS Vice President,Integrative SciencesBoard Observer
Adrian Krainer, PhD
Cold Spring Harbor LaboratoryRNA Drug DevelopmentSAB
Omar Abdel-Wahab, MD
Memorial Sloan KetteringLeukemia ResearchSABBacked by Premier Investors in Life Sciences
Driving Innovation Through Strategic Partnering
Learn moreEnvisagenics is dedicated to turning scientific innovation into life-changing therapies through the power of collaboration. Please connect to explore what’s possible.